Rheumatoid Arthritis
Malaria vaccine presentation
Antiviral chemotherapy
PARP-1 Inhibitors In Oncology
Biocon Investor Presentation_Sept_2011_Q1
Biocon Investor Presentation (October '11)
Clinical Research Methodology
Monitoring antifungal treatment response in neutropenic patient with aspergillosis Clóvis Arns da Cunha, MD Professor at Infectious Diseases Division,
First line therapy for IA ECIL II 2007IDSA 2008BSH 2008 VoriconazoleA I (oral CIII)A I (1° line)Recommended L-AMBB IA I (1° line for some pts)Recommended.
4 TH ANNUAL HEALTHCARE INFORMATICS SYMPOSIUM APRIL 29 TH, 2011 RICHARD RJ KEDZIORA Design and Implementation of a Diabetes Medication Computer Assisted.
Neurology NAPLEX. Drugs used for Convulsive Disorders NAPLEX PG 88.
Step-down or Step-off: How do we consider the warning about LABA from the FDA? Robert C. Strunk, MD Strominger Professor of Pediatrics Washington University.
